When CEA is used alone for early-stage CRC detection, the sensitivity ranges from 18.8% to 52.2%, while panels with CEA and the other four glycoproteins show a sensitivity of 85.3% and a specificity of 95% for early-stage CRC detection [11]. Here, CEACAM5 is linked to colorectal carcinoma.